ArticleBrain, behavior, and immunity2023
Intestinal epithelial stem cell transplants as a novel therapy for cerebrovascular stroke.
Open access · hybridAbstract read
In one paragraph
Article in Brain, behavior, and immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
- Sex differences in the effects of shift work-like schedules on gut microbiome and intestinal barrier in relation to stroke survival.PloS one · 2026Article
- Specific genetic and biological patterns underlying cortical morphological alterations in vascular cognitive impairment.Alzheimer's research & therapy · 2025Article
- Stem Cells in Regenerative Medicine: A Journey from Adult Stem Cells to Induced Pluripotent Cells.International journal of molecular sciences · 2025Review
- Prenatal alcohol exposure worsens acute but not long-term cognitive outcomes due to stroke in middle-aged Sprague-Dawley rat offspring.Alcohol, clinical & experimental research · 2025Article
- Systemic IGF-1 administration prevents traumatic brain injury induced gut permeability, dysmorphia, dysbiosis, and the increased number of immature dentate granule cells.Acta neuropathologica communications · 2025Article
- Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage.Translational stroke research · 2025Review
- Gastrointestinal Dysfunction and Dysbiosis in Ischemic Stroke: Opportunities for Therapeutic Intervention.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Gut Microbiota, Bacterial Translocation, and Stroke: Current Knowledge and Future Directions.Biomedicines · 2024Review
- Peripheral, but not central, IGF-1 treatment attenuates stroke-induced cognitive impairment in middle-aged female Sprague Dawley rats: The gut as a therapeutic target.Brain, behavior, and immunity · 2024Article
- Current applications of intestinal organoids: a review.Stem cell research & therapy · 2024Review
- Article
- Th17 Cells and IL-17A in Ischemic Stroke.Molecular neurobiology · 2024Review
- Exploring the common mechanism of vascular dementia and inflammatory bowel disease: a bioinformatics-based study.Frontiers in immunology · 2024Article
- Prenatal alcohol alters inflammatory signatures in enteric portal tissues following adult-onset cerebrovascular ischemic stroke.iScience · 2023Article
- Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models.International journal of molecular sciences · 2023Review
- The aging ovary impairs acute stroke outcomes.Journal of neuroinflammation · 2023Article
- Interventional strategies for ischemic stroke based on the modulation of the gut microbiota.Frontiers in neuroscience · 2023Review
- Microbiota and nutrition as risk and resiliency factors following prenatal alcohol exposure.Frontiers in neuroscience · 2023Review
Corrections and comments
- Commented on by
Authors and funding
9 authors at 2 institutions in 1 country.
Kathiresh Kumar ManiWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States; Texas A&M Institute for Neuroscience, Texas A&M University, Bryan, TX 77807, United States.
Yumna El-HakimWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Taylor E BranyanWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States; Texas A&M Institute for Neuroscience, Texas A&M University, Bryan, TX 77807, United States.
Nadia SamiyaWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Sivani PandeyWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Maria T GrimaldoWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Ali HabbalWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Anna WertzWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States.
Farida SohrabjiWomen's Health in Neuroscience Program, Department of Neuroscience and Experimental Therapeutics, College of Medicine, Mail Stop 1359 | 8447 Riverside Pkwy, Bryan, TX 77807-3260, United States; Texas A&M Institute for Neuroscience, Texas A&M University, Bryan, TX 77807, United States. Electronic address: f-sohrabji@tamu.edu.
Texas A&M Health Science Center · USTexas A&M University · US
Funding
Epigenetics of the Aging Astrocyte: Implications for StrokeRF1AG042189 · NIA · TEXAS A&M UNIVERSITY · PI SOHRABJI, FARIDA · 2018 to 2018
$2.8MTargeting the gut for stroke neuroprotection; IGF-1 modulation of the blood-gut barrierRF1NS119872 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BAKE, SHAMEENA, SOHRABJI, FARIDA · 2022 to 2022
$1.7MTargeting the Gut for Stroke Neuroprotection; IGF-1 Modulation of the Blood-Gut BarrierR01NS119872 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Shameena Bake, Farida Sohrabji · 2025 to 2026
$1.1MRole of Astrocytic miR-20a-3p as a Potential Therapeutic for Ischemic StrokeF31NS118970 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI BRANYAN, TAYLOR · 2021 to 2023
$106kNIA NIH HHS RF1 AG042189NINDS NIH HHS F31 NS118970NINDS NIH HHS R01 NS119872NINDS NIH HHS RF1 NS119872
Abstract
Almost 2/3
Indexed as
Motor DisordersPersons with DisabilitiesStrokeAnimalsHumansRatsStem Cell TransplantationIL17Intestinal epithelial stem cellsLgr5+OrganoidsPost stroke cognitive impairmentStrokeTransplant
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.